Ketamine therapy for opioid addiction
Treatments studied
Part of Mental health clinical trials.
This study tests if combining ketamine with a mindfulness program can help people who are still struggling with opioid use while on buprenorphine. If you are already taking buprenorphine but still using opioids, this treatment may offer additional support to help you stop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and speak English.
- You have been diagnosed with opioid use disorder.
- You are currently taking a buprenorphine medication (like Suboxone).
- You are still using opioids (either shown in a urine test or by your own report).
- You have a friend or family member who can drive you home after a ketamine session (no ride services allowed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether ketamine-assisted therapy can help people with opioid use disorder, alongside standard treatment with buprenorphine. It also looks at whether you can safely take part in group mindfulness-style sessions during the study.
This study tests if a medicine called ketamine, given during methadone treatment, can help people reduce their use of opioids. It is for people who recently started methadone and have been using opioids heavily.
This study tests if adding a medication called guanfacine and mindfulness meditation to standard buprenorphine treatment helps people with opioid use disorder. It looks at whether this combination can improve treatment outcomes and reduce opioid use.
This study tests whether adding psilocybin (a psychedelic medicine) to buprenorphine (a medication for opioid use disorder) can help people stop using opioids and stay in recovery. It is for people who have already been on buprenorphine but are still using other opioids.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This Phase 1 study tests how adding psilocybin to a standard opioid treatment (buprenorphine-naloxone) affects recovery and symptoms in people with moderate-to-severe opioid use disorder. It may help researchers understand whether this combination is safe and beneficial alongside medication for opioid withdrawal and cravings.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.